The Beauty Health Company
SKIN
$1.40
-$0.06-4.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -13.15% | -15.34% | -17.97% | -16.00% | -12.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.15% | -15.34% | -17.97% | -16.00% | -12.94% |
| Cost of Revenue | -38.22% | -51.03% | -42.58% | -37.42% | -23.01% |
| Gross Profit | 11.41% | 55.75% | 22.19% | 17.52% | -0.16% |
| SG&A Expenses | -11.31% | -9.34% | -10.60% | -11.65% | -12.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.63% | -30.12% | -26.43% | -23.98% | -17.05% |
| Operating Income | 64.39% | 68.91% | 51.91% | 48.23% | 31.33% |
| Income Before Tax | 51.76% | 77.00% | 52.82% | 71.00% | 69.50% |
| Income Tax Expenses | -171.67% | -85.05% | -10.65% | 74.51% | 149.15% |
| Earnings from Continuing Operations | 58.31% | 77.29% | 52.18% | 70.94% | 66.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.31% | 77.29% | 52.18% | 70.94% | 66.53% |
| EBIT | 64.39% | 68.91% | 51.91% | 48.23% | 31.33% |
| EBITDA | 96.26% | 84.90% | 66.20% | 64.57% | 50.31% |
| EPS Basic | 58.02% | 75.54% | 49.16% | 69.02% | 64.71% |
| Normalized Basic EPS | 48.89% | 67.88% | 42.57% | 36.91% | 30.66% |
| EPS Diluted | 47.12% | 65.93% | 41.19% | 43.74% | 38.59% |
| Normalized Diluted EPS | 44.26% | 66.39% | 43.40% | 41.77% | 36.29% |
| Average Basic Shares Outstanding | 0.57% | -1.74% | -3.90% | -5.97% | -6.83% |
| Average Diluted Shares Outstanding | -4.18% | -6.24% | -4.33% | 1.54% | 0.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |